Free Trial

Vanda Pharmaceuticals (VNDA) News Today

$6.24
-0.26 (-4.00%)
(As of 06/14/2024 ET)
GSA Capital Partners LLP Boosts Holdings in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)
GSA Capital Partners LLP lifted its stake in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA - Free Report) by 39.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 567,756 shares of the biopharmaceut
Trexquant Investment LP Sells 169,741 Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)
Trexquant Investment LP reduced its stake in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA - Free Report) by 61.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 104,511 sha
Short Interest in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Rises By 21.7%
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA - Get Free Report) saw a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 2,800,000 shares, an increase of 21.7% from the April 30th total of 2,300,000 shares. Currently, 5.1% of the shares of the stock are short sold. Based on an average trading volume of 2,350,000 shares, the days-to-cover ratio is presently 1.2 days.
Assenagon Asset Management S.A. Cuts Position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)
Assenagon Asset Management S.A. lessened its holdings in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA - Free Report) by 54.0% during the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 730,820 shares of the biopharmaceutical company's stock after sellin
Q1 2024 Vanda Pharmaceuticals Inc Earnings Call
Vanda Pharmaceuticals (VNDA) Set to Announce Quarterly Earnings on Wednesday
Vanda Pharmaceuticals (NASDAQ:VNDA) will be releasing earnings after the market closes on Wednesday, May 8, Zacks reports.

VNDA Media Mentions By Week

VNDA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VNDA
News Sentiment

0.58

0.91

Average
Medical
News Sentiment

VNDA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VNDA Articles
This Week

8

3

VNDA Articles
Average Week

Get Vanda Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for VNDA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:VNDA) was last updated on 6/16/2024 by MarketBeat.com Staff

From Our Partners